8.19
price up icon1.24%   0.10
after-market アフターアワーズ: 8.17 -0.02 -0.24%
loading
前日終値:
$8.09
開ける:
$8.15
24時間の取引高:
911.65K
Relative Volume:
0.70
時価総額:
$1.06B
収益:
$175.51M
当期純損益:
$-78.02M
株価収益率:
-15.45
EPS:
-0.53
ネットキャッシュフロー:
$-34.18M
1週間 パフォーマンス:
+4.46%
1か月 パフォーマンス:
+0.86%
6か月 パフォーマンス:
-8.29%
1年 パフォーマンス:
+51.95%
1日の値動き範囲:
Value
$8.13
$8.34
1週間の範囲:
Value
$7.80
$8.34
52週間の値動き範囲:
Value
$5.15
$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Name
名前
Aurinia Pharmaceuticals Inc
Name
セクター
Healthcare (1170)
Name
電話
250-744-2487
Name
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
Name
職員
300
Name
Twitter
@AuriniaPharma
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
AUPH's Discussions on Twitter

AUPH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AUPH
Aurinia Pharmaceuticals Inc
8.19 1.06B 175.51M -78.02M -34.18M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 113.52B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 52.93B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
300.83 39.71B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
585.93 35.00B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.57B 3.81B -644.79M -669.77M -6.24

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-11-04 ダウングレード Oppenheimer Outperform → Perform
2022-05-05 再開されました Cantor Fitzgerald Overweight
2021-12-10 アップグレード Oppenheimer Perform → Outperform
2021-10-28 ダウングレード Oppenheimer Outperform → Perform
2021-01-25 繰り返されました H.C. Wainwright Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-06-17 開始されました BTIG Research Buy
2020-05-05 開始されました Cowen Outperform
2020-01-10 開始されました Jefferies Buy
2019-12-16 繰り返されました H.C. Wainwright Buy
2018-03-16 繰り返されました Cantor Fitzgerald Overweight
2018-02-08 開始されました RBC Capital Mkts Outperform
2017-10-30 繰り返されました H.C. Wainwright Buy
2017-05-18 繰り返されました H.C. Wainwright Buy
2017-04-11 開始されました Cantor Fitzgerald Overweight
2017-03-22 繰り返されました FBR & Co. Outperform
2016-12-30 繰り返されました H.C. Wainwright Buy
2016-08-17 繰り返されました H.C. Wainwright Buy
2016-06-30 開始されました H.C. Wainwright Buy
2015-05-08 開始されました MLV & Co Buy
すべてを表示

Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース

pulisher
Jun 06, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SDIG, AUPH and LICY - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

(AUPH) Trading Signals - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.27 Million Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - InsuranceNewsNet

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Acquires 26,981 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Jun 06, 2025
pulisher
Jun 03, 2025

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AUPH, IRNT and RSKD - ACCESS Newswire

Jun 03, 2025
pulisher
May 31, 2025

Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock? - MSN

May 31, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Sells 14,003 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 31, 2025
pulisher
May 30, 2025

Is The Options Market Predicting A Spike In Aurinia Pharmaceuticals (AUPH) Stock? - Barchart.com

May 30, 2025
pulisher
May 28, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 28, 2025
pulisher
May 27, 2025

Nuveen Asset Management LLC Increases Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 27, 2025
pulisher
May 27, 2025

Cetera Investment Advisers Purchases 2,000 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 27, 2025
pulisher
May 27, 2025

(AUPH) Technical Data - news.stocktradersdaily.com

May 27, 2025
pulisher
May 26, 2025

Deutsche Bank AG Purchases 50,575 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 26, 2025
pulisher
May 22, 2025

Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial R - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aurinia Pharmaceuticals (AUPH) Reports Positive Lupkinis Trial Results | AUPH Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Aurinia Pharmaceuticals’ LUPKYNIS Shows Promising Results in Lupus Nephritis Study - TipRanks

May 22, 2025
pulisher
May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Strong Earnings Are Of Good Quality - simplywall.st

May 19, 2025
pulisher
May 19, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

May 19, 2025
pulisher
May 16, 2025

Aurinia Pharmaceuticals Inc. Just Recorded A 60% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Has Positive Outlook of AUPH Q2 Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals Approves New Equity Incentive Plan - TipRanks

May 15, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Transcript : Aurinia Pharmaceuticals Inc.Shareholder/Analyst Call - marketscreener.com

May 15, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - MSN

May 14, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals Financial Update and Strategic Growth Plans - Zenopa

May 14, 2025
pulisher
May 14, 2025

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Price T Rowe Associates Inc. MD Has $468,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 14, 2025
pulisher
May 13, 2025

Aurinia outlines $250M–$260M 2025 revenue target as LUPKYNIS sales climb 25% and operational efficiency improves - MSN

May 13, 2025
pulisher
May 13, 2025

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks

May 12, 2025
pulisher
May 12, 2025

Document - SEC.gov

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aurinia: Q1 Earnings Snapshot - MySA

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

May 12, 2025
pulisher
May 12, 2025

Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens - Investing.com India

May 12, 2025
pulisher
May 12, 2025

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals' Q1 Swings to Profit, Revenue Rises; Reiterates 2025 Revenue Guidance - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Inc. Reiterates Guidance for the Full Year 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025 - Business Wire

May 12, 2025
pulisher
May 09, 2025

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

May 09, 2025
pulisher
May 06, 2025

How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025 - BioSpace

May 05, 2025
pulisher
May 01, 2025

Invesco Ltd. Acquires 1,421 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

May 01, 2025

Aurinia Pharmaceuticals Inc (AUPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):